Mathieu Heulot

Learn More
The increase of cancer specificity and efficacy of anti-tumoral agents are prime strategies to overcome the deleterious side effects associated with anti-cancer treatments. We described earlier a cell-permeable protease-resistant peptide derived from the p120 RasGAP protein, called TAT-RasGAP317–326, as being an efficient tumor-specific sensitizer to(More)
  • 1